Literature DB >> 9043038

Mammography screening interval and the frequency of interval cancers in a population-based screening.

P J Klemi1, S Toikkanen, O Räsänen, I Parvinen, H Joensuu.   

Abstract

In a population-based mammography screening, 129,731 examinations were carried out among 36,000 women aged 40-74 in the city of Turku, Finland, in the period 1987-94. Women older than 50 were screened at 2-year intervals, and those younger than 50 at either 1-year or 3-year intervals, depending on their year of birth. Screen-detected breast cancers numbered 385 and, during the same time period, 154 women were diagnosed with breast cancer outside screening in the same age group in the same city, and 100 interval cancers were detected. Two hundred and fifty (67%) of the screen-detected cancers were of post-surgical stage I compared with 45 (45%) of the interval cancers and 52 (34%) of the cancers found outside screening (P<0.0001). However, among women aged 40-49 the frequency of stage I cancers did not differ significantly among screen-detected cancers, interval cancers and cancers found outside screening (50%, 42% and 44% respectively; P=0.73). Invasive interval cancers were more frequent among women aged 40-49 if screening was done at either 1-year (27%) or 3-year intervals (39%) than in older women screened at 2-year intervals (18%; P=0.08 and P=0.0009 respectively). Even if adjusted for the primary tumour size, screen-detected cancers had smaller S-phase fractions than interval cancers or control cancers (P=0.01), but no difference in the S-phase fraction size was found between cancers of women younger than 50 and those older than this (P=0.13). We conclude that more interval cancers were found among women younger than 50 than among those older than 50 and that this could not be explained by the rate of cancer cell proliferation.

Entities:  

Mesh:

Year:  1997        PMID: 9043038      PMCID: PMC2063348          DOI: 10.1038/bjc.1997.135

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials.

Authors:  C R Smart; R E Hendrick; J H Rutledge; R A Smith
Journal:  Cancer       Date:  1995-04-01       Impact factor: 6.860

2.  Breast cancer incidence and mortality in the breast cancer detection demonstration project [published errtum appears in J Natl Cancer Inst 1989 Oct 4;81(19):1513].

Authors:  A S Morrison; J Brisson; N Khalid
Journal:  J Natl Cancer Inst       Date:  1988-12-07       Impact factor: 13.506

3.  Efficacy of screening mammography. A meta-analysis.

Authors:  K Kerlikowske; D Grady; S M Rubin; C Sandrock; V L Ernster
Journal:  JAMA       Date:  1995-01-11       Impact factor: 56.272

4.  The National Cancer Institute and guideline development: lessons from the breast cancer screening controversy.

Authors:  A D Kaluzny; B Rimer; R Harris
Journal:  J Natl Cancer Inst       Date:  1994-06-15       Impact factor: 13.506

5.  Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations.

Authors:  D M Ikeda; I Andersson; C Wattsgård; L Janzon; F Linell
Journal:  AJR Am J Roentgenol       Date:  1992-08       Impact factor: 3.959

6.  Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.

Authors:  H J Burhenne; L W Burhenne; F Goldberg; T G Hislop; A J Worth; P M Rebbeck; L Kan
Journal:  AJR Am J Roentgenol       Date:  1994-05       Impact factor: 3.959

7.  Comparison of breast carcinomas diagnosed in the 1980s with those diagnosed in the 1940s to 1960s.

Authors:  H Joensuu; S Toikkanen
Journal:  BMJ       Date:  1991-07-20

8.  Interval cancers and sensitivity in the screening centres of the UK trial of early detection of breast cancer.

Authors:  S M Moss; D A Coleman; R Ellman; J Chamberlain; A P Forrest; A E Kirkpatrick; B A Thomas; J L Price
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

9.  The occurrence of interval cancers in the Nijmegen screening programme.

Authors:  P H Peeters; A L Verbeek; J H Hendriks; R Holland; M Mravunac; G P Vooijs
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

10.  The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.

Authors:  S Toikkanen; H Joensuu; P Klemi
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

View more
  12 in total

1.  Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survival.

Authors:  A M Brewster; P Thompson; A A Sahin; K Do; M Edgerton; J L Murray; S Tsavachidis; R Zhou; Y Liu; L Zhang; G Mills; M Bondy
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-27

2.  Differential expression of prognostic biomarkers between interval and screen-detected breast cancers: does age or family history matter?

Authors:  Jan T Lowery; Tim Byers; John Kittelson; John E Hokanson; Judy Mouchawar; John Lewin; Dan Merrick; Lisa Hines; Meenakshi Singh
Journal:  Breast Cancer Res Treat       Date:  2011-03-24       Impact factor: 4.872

3.  External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening Mammograms.

Authors:  Mattie Salim; Erik Wåhlin; Karin Dembrower; Edward Azavedo; Theodoros Foukakis; Yue Liu; Kevin Smith; Martin Eklund; Fredrik Strand
Journal:  JAMA Oncol       Date:  2020-10-01       Impact factor: 31.777

4.  Impact of a mammography screening programme on the breast cancer population of the Region of Valencia (Spain).

Authors:  Jose Alejandro Pérez-Fidalgo; Josefa Miranda; Isabel Chirivella; Josefa Ibáñez; Begona Bermejo; Carmen Pons; Inmaculada Melchor; Ana Santaballa; Francisco Martínez-Ruiz; Ana Lluch; Dolores Salas
Journal:  Clin Transl Oncol       Date:  2008-11       Impact factor: 3.405

5.  Breast Cancer Screening in Asian Women with Dense Breast by Mammography: A Cross-Sectional Observational Study.

Authors:  Jung Sun Lee; Minkyung Oh
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01

6.  Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals.

Authors:  N T van Ravesteyn; E A M Heijnsdijk; G Draisma; H J de Koning
Journal:  Br J Cancer       Date:  2011-08-23       Impact factor: 7.640

7.  Long-term prognosis of breast cancer detected by mammography screening or other methods.

Authors:  Tiina Lehtimäki; Mikael Lundin; Nina Linder; Harri Sihto; Kaija Holli; Taina Turpeenniemi-Hujanen; Vesa Kataja; Jorma Isola; Heikki Joensuu; Johan Lundin
Journal:  Breast Cancer Res       Date:  2011-12-28       Impact factor: 6.466

Review 8.  Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers.

Authors:  R A Eeles
Journal:  Breast Cancer Res       Date:  2000-05-25       Impact factor: 6.466

9.  Interval cancers in the Dutch breast cancer screening programme.

Authors:  J Fracheboud; H J de Koning; P M Beemsterboer; R Boer; A L Verbeek; J H Hendriks; B M van Ineveld; M J Broeders; A E de Bruyn; P J van der Maas
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

10.  Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer.

Authors:  P Kronqvist; T Kuopio; P Jalava; Y Collan
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.